Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of ABBOTT INDIA. For more details, see the ABBOTT INDIA quarterly results and ABBOTT INDIA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.8 |
No. of shares | m | 21.25 |
1 Week | % | -0.7 |
1 Month | % | -3.1 |
1 Year | % | 16.0 |
52 week H/L | Rs | 29,628.2/20,594.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ABBOTT INDIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 8,834 | 16,869 | 18,569 | 23,902 | 22,482 | |
Low | Rs | 5,458 | 7,150 | 13,970 | 14,553 | 16,156 | |
Sales per share (Unadj.) | Rs | 1,731.1 | 1,926.2 | 2,028.2 | 2,312.2 | 2,517.0 | |
Earnings per share (Unadj.) | Rs | 211.9 | 279.0 | 325.0 | 375.9 | 446.8 | |
Diluted earnings per share | Rs | 211.9 | 279.0 | 325.0 | 375.9 | 446.8 | |
Cash flow per share (Unadj.) | Rs | 219.9 | 307.1 | 352.4 | 407.0 | 479.7 | |
Dividends per share (Unadj.) | Rs | 65.00 | 250.00 | 275.00 | 275.00 | 325.00 | |
Adj. dividends per share | Rs | 65.00 | 250.01 | 275.01 | 275.01 | 325.01 | |
Avg Dividend yield | % | 0.9 | 2.1 | 1.7 | 1.4 | 1.7 | |
Book value per share (Unadj.) | Rs | 932.2 | 1,127.5 | 1,203.7 | 1,306.2 | 1,480.5 | |
Adj. book value per share | Rs | 932.2 | 1,127.5 | 1,203.8 | 1,306.2 | 1,480.5 | |
Shares outstanding (eoy) | m | 21.25 | 21.25 | 21.25 | 21.25 | 21.25 | |
Price / Sales ratio | x | 4.1 | 6.2 | 8.0 | 8.3 | 7.7 | |
Avg P/E ratio | x | 33.7 | 43.0 | 50.1 | 51.2 | 43.2 | |
P/CF ratio (eoy) | x | 32.5 | 39.1 | 46.2 | 47.2 | 40.3 | |
Price / Book Value ratio | x | 7.7 | 10.7 | 13.5 | 14.7 | 13.0 | |
Dividend payout | % | 30.7 | 89.6 | 84.6 | 73.2 | 72.7 | |
Avg Mkt Cap | Rs m | 151,843 | 255,193 | 345,717 | 408,573 | 410,513 | |
Total wages/salary | Rs m | 4,356 | 4,761 | 4,927 | 5,795 | 5,636 |
ABBOTT INDIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 36,786 | 40,931 | 43,100 | 49,133 | 53,487 | |
Other income | Rs m | 1,140 | 1,147 | 835 | 834 | 1,543 | |
Total revenues | Rs m | 37,926 | 42,078 | 43,935 | 49,967 | 55,030 | |
Gross profit | Rs m | 6,040 | 7,562 | 9,189 | 10,816 | 12,055 | |
Depreciation | Rs m | 169 | 596 | 581 | 661 | 700 | |
Interest | Rs m | 22 | 85 | 183 | 191 | 160 | |
Profit before tax | Rs m | 6,989 | 8,027 | 9,260 | 10,797 | 12,738 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,485 | 2,098 | 2,353 | 2,810 | 3,244 | |
Profit after tax | Rs m | 4,503 | 5,929 | 6,907 | 7,987 | 9,494 | |
Gross profit margin | % | 16.4 | 18.5 | 21.3 | 22.0 | 22.5 | |
Effective tax rate | % | 35.6 | 26.1 | 25.4 | 26.0 | 25.5 | |
Net profit margin | % | 12.2 | 14.5 | 16.0 | 16.3 | 17.8 |
ABBOTT INDIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 27,610 | 32,047 | 34,874 | 38,530 | 30,251 | |
Current liabilities | Rs m | 8,569 | 8,911 | 10,309 | 12,032 | 12,060 | |
Net working cap to sales | % | 51.8 | 56.5 | 57.0 | 53.9 | 34.0 | |
Current ratio | x | 3.2 | 3.6 | 3.4 | 3.2 | 2.5 | |
Inventory Days | Days | 6 | 5 | 7 | 6 | 87 | |
Debtors Days | Days | 274 | 3 | 2 | 2 | 2 | |
Net fixed assets | Rs m | 1,669 | 3,278 | 3,352 | 3,541 | 15,135 | |
Share capital | Rs m | 212 | 213 | 213 | 213 | 213 | |
"Free" reserves | Rs m | 19,596 | 23,747 | 25,366 | 27,544 | 31,248 | |
Net worth | Rs m | 19,808 | 23,959 | 25,579 | 27,756 | 31,460 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 29,278 | 35,324 | 38,226 | 42,072 | 45,386 | |
Interest coverage | x | 311.9 | 95.1 | 51.7 | 57.5 | 80.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.3 | 1.2 | 1.1 | 1.2 | 1.2 | |
Return on assets | % | 15.5 | 17.0 | 18.5 | 19.4 | 21.3 | |
Return on equity | % | 22.7 | 24.7 | 27.0 | 28.8 | 30.2 | |
Return on capital | % | 35.4 | 33.9 | 36.9 | 39.6 | 41.0 | |
Exports to sales | % | 0.5 | 0.3 | 0.7 | 0.7 | 0.4 | |
Imports to sales | % | 13.1 | 12.7 | 12.3 | 10.2 | 10.8 | |
Exports (fob) | Rs m | 180 | 118 | 295 | 350 | 221 | |
Imports (cif) | Rs m | 4,819 | 5,195 | 5,306 | 5,034 | 5,765 | |
Fx inflow | Rs m | 369 | 332 | 353 | 415 | 310 | |
Fx outflow | Rs m | 4,918 | 5,281 | 5,389 | 5,117 | 5,818 | |
Net fx | Rs m | -4,549 | -4,949 | -5,035 | -4,702 | -5,508 |
ABBOTT INDIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 4,991 | 6,261 | 7,267 | 9,477 | 8,934 | |
From Investments | Rs m | -2,570 | -4,012 | -718 | -3,958 | -1,477 | |
From Financial Activity | Rs m | -1,428 | -2,168 | -5,818 | -6,374 | -6,387 | |
Net Cashflow | Rs m | 993 | 81 | 731 | -856 | 1,070 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Munir Shaikh | COMP SEC: Krupa Anandpara | YEAR OF INC: 1944 | BSE CODE: 500488 | FV (Rs): 10 | DIV YIELD (%): 1.3 |
Read: ABBOTT INDIA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ABBOTT INDIA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.